Clinical features of Sézary syndrome patients (N = 9)
| Patient no. . | Age, y . | Sex . | CD4+CD7− cells, % . | Sézary cells by peripheral blood smear, % . | Total CD4+ cells, % . | TCR clonality . |
|---|---|---|---|---|---|---|
| 1* | 74 | Male | 98 | > 10 | 95 | Yes |
| 2* | 64 | Female | 87 | > 10 | 94 | No |
| 3* | 75 | Female | 91 | > 5 | 96 | No |
| 4* | 80 | Female | 84 | > 5 | 80 | Yes |
| 5* | 70 | NA | 95 | > 90 | NA | Yes |
| 6* | 60 | Male | 90 | > 10 | 95 | Yes |
| 7 | 73 | Male | 27 | > 5 | 54 | Yes |
| 8 | 59 | Male | 76 | > 5 | 88 | No |
| 9 | 52 | Male | 8 | > 5 | 85 | Yes |
| Patient no. . | Age, y . | Sex . | CD4+CD7− cells, % . | Sézary cells by peripheral blood smear, % . | Total CD4+ cells, % . | TCR clonality . |
|---|---|---|---|---|---|---|
| 1* | 74 | Male | 98 | > 10 | 95 | Yes |
| 2* | 64 | Female | 87 | > 10 | 94 | No |
| 3* | 75 | Female | 91 | > 5 | 96 | No |
| 4* | 80 | Female | 84 | > 5 | 80 | Yes |
| 5* | 70 | NA | 95 | > 90 | NA | Yes |
| 6* | 60 | Male | 90 | > 10 | 95 | Yes |
| 7 | 73 | Male | 27 | > 5 | 54 | Yes |
| 8 | 59 | Male | 76 | > 5 | 88 | No |
| 9 | 52 | Male | 8 | > 5 | 85 | Yes |
NA indicates information not available.
Patients 1 to 6 were included in transcriptional profiling analysis.